A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder
PHASE1CompletedINTERVENTIONAL
Enrollment
64
Participants
Timeline
Start Date
September 30, 2006
Study Completion Date
March 31, 2007
Conditions
SchizophreniaBipolar Disorder
Interventions
DRUG
paliperidone ER; Carbamazepine
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00892125 - A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder | Biotech Hunter | Biotech Hunter